| This week's sponsor is TD2. | | | |
Featured Story | | | Monday, September 25, 2017 In a first for the Big Pharma and as part of a new model, Pfizer is taking drugs from its shelves and licensing them to, while investing in, its SpringWorks Therapeutics startup. |
|
|
| This week's sponsor is FierceBiotech. | | | FierceBiotech Executive Summit- London
Join FierceBiotech for our third annual Executive Summit in London. We'll gather the experts together to discuss innovation around R&D in the UK and look ahead to what's in store for 2018 with leaders in the field discussing trends in the industry. |
Top Stories Monday, September 25, 2017 The FDA has delivered its expected rejection of Johnson & Johnson’s rheumatoid arthritis drug sirukumab. J&J is now assessing what it will take to quell the agency’s concerns about the safety of the IL-6 monoclonal antibody before deciding on a path forward. Monday, September 25, 2017 AstraZeneca has struck a deal to combine its anti-PD-L1 drug with NewLink Genetics’ IDO pathway inhibitor. The collaborators will jointly fund a phase 2 trial of the combination in pancreatic cancer patients. Monday, September 25, 2017 RBM shouldn’t be a point of concern, but rather a point of validation of what matters. It’s, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site-and patient-centric environment. Monday, September 25, 2017 With a positive phase 3 trial in hand, Japan’s Daiichi Sankyo plans to file its essential hypertension therapy esaxerenone in its home market next year. Monday, September 25, 2017 Gelesis has claimed success in a pivotal trial of its obesity candidate. More than half of participants who took the swelling hydrogel particles lost weight, encouraging Gelesis to file for approval despite missing the other co-primary endpoint. Monday, September 25, 2017 Scientists at the National Institute of Standards and Technology have created a rapid test that indicates if an antibiotic fights a given infection, which could speed up treatments and reduce improperly prescribed antibiotics. Monday, September 25, 2017 Bristol-Myers Squibb’s Opdivo has won another FDA approval—and the right to take on Bayer in liver cancer. The immuno-oncology standout is now cleared for patients who've already been treated with Bayer’s Nexavar, the same group targeted by the German drugmaker's follow-up drug Stivarga. | This week's sponsor is CMed. | | | |
Resources Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Life Sciences Innovation Awards | Don't Miss This Opportunity Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 